Skip to main content
Erschienen in: International Ophthalmology 1/2018

06.05.2017 | Original Paper

Is there an association between glaucoma and capillaroscopy in patients with systemic sclerosis?

verfasst von: Beatriz Fiuza Gomes, Rebeca Souza, Thiago Valadão, Newton Kara-Junior, Haroldo Vieira Moraes, Marcony R. Santhiago

Erschienen in: International Ophthalmology | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the relationship between glaucoma diagnosis and the nailfold capillaroscopy pattern in patients with systemic sclerosis.

Methods

An observational study in a cohort of patients with SSc was conducted. Patients with at least one nailfold videocapillaroscopy and one ophthalmology examination at the same year were included. Data collected were: age, sex; type of systemic sclerosis according to the degree of skin impairment, self-reported ethnicity, disease duration, current use and dosage of systemic corticosteroid, current use and dosage of bosentan®, intraocular pressure, central corneal thickness, diagnosis of glaucoma and capillaroscopy pattern.

Results

Thirty-one patients with systemic sclerosis were enrolled, 23% had glaucoma. There was no statistically significant association between glaucoma diagnosis and the capillaroscopic pattern (p = 0.86). There was also no significant difference (p = 0.66) regarding intraocular pressure between patients with mild (13.9 ± 3.8 mmHg) and severe capillaroscopic pattern (14.4 ± 2.8 mmHg). The odds ratio of glaucoma for severe capillaroscopic pattern compared to mild was 1.6 (95% confidence interval: 0.3–9.5).

Conclusion

Up to 23% of patients with SSc have glaucoma. The high prevalence of glaucoma in SSc suggests a possible systemic vascular disturbance as the cause. However, there seems to be no significant association between the capillaroscopy pattern and glaucoma in systemic sclerosis. Further research is required to improve the understanding of glaucoma in the context of systemic sclerosis.
Literatur
1.
Zurück zum Zitat Allanore Y, Avouac J, Wipff J, Kahan A (2007) New therapeutic strategies in the management of systemic sclerosis. Expert Opin Pharmacother 8:607–615CrossRefPubMed Allanore Y, Avouac J, Wipff J, Kahan A (2007) New therapeutic strategies in the management of systemic sclerosis. Expert Opin Pharmacother 8:607–615CrossRefPubMed
2.
Zurück zum Zitat Abraham DJ, Krieg T, Distler J, Distler O (2009) Overview of pathogenesis of systemic sclerosis. Rheumatology 48:3–7CrossRef Abraham DJ, Krieg T, Distler J, Distler O (2009) Overview of pathogenesis of systemic sclerosis. Rheumatology 48:3–7CrossRef
3.
Zurück zum Zitat Gomes BA, Santhiago M, Magalhães P, Kara-Junior N, Azevedo M, Moraes HJ (2011) Ocular findings in patients with systemic sclerosis. Clinics (Sao Paulo). 66(3):379–385CrossRef Gomes BA, Santhiago M, Magalhães P, Kara-Junior N, Azevedo M, Moraes HJ (2011) Ocular findings in patients with systemic sclerosis. Clinics (Sao Paulo). 66(3):379–385CrossRef
4.
Zurück zum Zitat Allanore Y, Parc C, Monnet D, Brézin A, Kahan A (2004) Increased prevalence of ocular glaucomatous abnormalities in systemic sclerosis. Ann Rheum Dis 63(10):1276–1278CrossRefPubMedPubMedCentral Allanore Y, Parc C, Monnet D, Brézin A, Kahan A (2004) Increased prevalence of ocular glaucomatous abnormalities in systemic sclerosis. Ann Rheum Dis 63(10):1276–1278CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Yamamoto T, Maeda M, Sawada A, Sugiyama K, Taniguchi T, Kitazawa Y et al (1999) Prevalence of normal-tension glaucoma and primary open-angle glaucoma in patients with collagen diseases. Jpn J Ophthalmol 43(6):539–542CrossRefPubMed Yamamoto T, Maeda M, Sawada A, Sugiyama K, Taniguchi T, Kitazawa Y et al (1999) Prevalence of normal-tension glaucoma and primary open-angle glaucoma in patients with collagen diseases. Jpn J Ophthalmol 43(6):539–542CrossRefPubMed
6.
Zurück zum Zitat Kitsos G, Tsifetaki N, Gorezis S, Drosos A (2007) Glaucomatous type abnormalities in patients with systemic sclerosis. Clin Exp Rheumatol 25(2):341PubMed Kitsos G, Tsifetaki N, Gorezis S, Drosos A (2007) Glaucomatous type abnormalities in patients with systemic sclerosis. Clin Exp Rheumatol 25(2):341PubMed
7.
Zurück zum Zitat Waszczykowska A, Goś R, Waszczykowska E, Dziankowska-Bartkowiak B, Jurowski P (2013) Prevalence of ocular manifestations in systemic sclerosis patients. Arch Med Sci 9(6):1107–1113CrossRefPubMedPubMedCentral Waszczykowska A, Goś R, Waszczykowska E, Dziankowska-Bartkowiak B, Jurowski P (2013) Prevalence of ocular manifestations in systemic sclerosis patients. Arch Med Sci 9(6):1107–1113CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160PubMed Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160PubMed
9.
Zurück zum Zitat Ghizzoni C, Sebastiani M, Manfredi A, Campomori F, Colaci M, Giuggioli D, Ferri C (2015) Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: clinical and prognostic implications. Microvasc Res 99:92–95CrossRefPubMed Ghizzoni C, Sebastiani M, Manfredi A, Campomori F, Colaci M, Giuggioli D, Ferri C (2015) Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: clinical and prognostic implications. Microvasc Res 99:92–95CrossRefPubMed
10.
Zurück zum Zitat Cutolo M, Sulli A, Smith V (2010) Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol 6(10):578–587CrossRefPubMed Cutolo M, Sulli A, Smith V (2010) Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol 6(10):578–587CrossRefPubMed
11.
Zurück zum Zitat LeRoy EC, Black CM, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed LeRoy EC, Black CM, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed
12.
Zurück zum Zitat Cutolo M, Pizzorni C, Sulli A (2005) Capillaroscopy. Best Pract Res Clin Rheumatol 19:437–452CrossRefPubMed Cutolo M, Pizzorni C, Sulli A (2005) Capillaroscopy. Best Pract Res Clin Rheumatol 19:437–452CrossRefPubMed
13.
Zurück zum Zitat Ko-Ming L, Cheng TT, Cheung-Jen C (2009) Clinical applications of nailfold capillaroscopy in different rheumatic diseases. J Intern Med 20:238–247 Ko-Ming L, Cheng TT, Cheung-Jen C (2009) Clinical applications of nailfold capillaroscopy in different rheumatic diseases. J Intern Med 20:238–247
14.
Zurück zum Zitat Smith V, Decuman S, Sulli A, Bonroy C, Piettte Y, Deschepper E, de Keyser F, Cutolo M (2012) Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study. Ann Rheum Dis 71(10):1636–1639CrossRefPubMed Smith V, Decuman S, Sulli A, Bonroy C, Piettte Y, Deschepper E, de Keyser F, Cutolo M (2012) Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study. Ann Rheum Dis 71(10):1636–1639CrossRefPubMed
15.
16.
Zurück zum Zitat Emre M, Orgul S, Gugleta K et al (2004) Ocular blood flow alteration in glaucoma is related to systemic vascular dysregulation. Br J Ophthalmol 88:662–666CrossRefPubMedPubMedCentral Emre M, Orgul S, Gugleta K et al (2004) Ocular blood flow alteration in glaucoma is related to systemic vascular dysregulation. Br J Ophthalmol 88:662–666CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Tailor R, Gupta A, Herrick A, Kwartz J (2009) Ocular manifestations of scleroderma. Surv Ophthalmol 54(2):292–304CrossRefPubMed Tailor R, Gupta A, Herrick A, Kwartz J (2009) Ocular manifestations of scleroderma. Surv Ophthalmol 54(2):292–304CrossRefPubMed
18.
Zurück zum Zitat Balbir-Gurman A, Braun-Moscovici Y (2012) Scleroderma—new aspects in pathogenesis and treatment. Best Pract Res Clin Rheumatol 26:13–24CrossRefPubMed Balbir-Gurman A, Braun-Moscovici Y (2012) Scleroderma—new aspects in pathogenesis and treatment. Best Pract Res Clin Rheumatol 26:13–24CrossRefPubMed
19.
Zurück zum Zitat Hasegawa M (2016) Biomarkers in systemic sclerosis: their potential to predict clinical courses. J Dermatol 43(1):29–38CrossRefPubMed Hasegawa M (2016) Biomarkers in systemic sclerosis: their potential to predict clinical courses. J Dermatol 43(1):29–38CrossRefPubMed
20.
Zurück zum Zitat Cabral-Marques O, Riemekasten G (2016) Vascular hypothesis revisited: role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis. Autoimmun Rev 15(7):690–694CrossRefPubMed Cabral-Marques O, Riemekasten G (2016) Vascular hypothesis revisited: role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis. Autoimmun Rev 15(7):690–694CrossRefPubMed
21.
Zurück zum Zitat Polak K, Luksch A, Frank B, Jandrasits K, Polska E, Schmetterer L (2003) Regulation of human retinal blood flow by endothelin-1. Exp Eye Res 76:633–640CrossRefPubMed Polak K, Luksch A, Frank B, Jandrasits K, Polska E, Schmetterer L (2003) Regulation of human retinal blood flow by endothelin-1. Exp Eye Res 76:633–640CrossRefPubMed
22.
Zurück zum Zitat Resch H, Karl K, Weigert G, Wolzt M, Hommer A, Schmetterer L, Garhöfer G (2009) Effect of dual endothelin receptor blockade on ocular blood flow in patients with glaucoma and healthy subjects. Invest Ophthalmol Vis Sci 50(1):358–363CrossRefPubMed Resch H, Karl K, Weigert G, Wolzt M, Hommer A, Schmetterer L, Garhöfer G (2009) Effect of dual endothelin receptor blockade on ocular blood flow in patients with glaucoma and healthy subjects. Invest Ophthalmol Vis Sci 50(1):358–363CrossRefPubMed
23.
Zurück zum Zitat Yorio T, Krishnamoorthy R, Prasanna G (2002) Endothelin: is it a contributor to glaucoma pathophysiology? J Glaucoma 11:259–270CrossRefPubMed Yorio T, Krishnamoorthy R, Prasanna G (2002) Endothelin: is it a contributor to glaucoma pathophysiology? J Glaucoma 11:259–270CrossRefPubMed
24.
Zurück zum Zitat Dismuke WM, Liang J, Overby DR, Stamer WD (2014) Concentration-related effects of nitric oxide and endothelin-1 on human trabecular meshwork cell contractility. Exp Eye Res 120:28–35CrossRefPubMed Dismuke WM, Liang J, Overby DR, Stamer WD (2014) Concentration-related effects of nitric oxide and endothelin-1 on human trabecular meshwork cell contractility. Exp Eye Res 120:28–35CrossRefPubMed
25.
Zurück zum Zitat Emre S, Kayikçioğlu O, Ateş H, Cinar E, Inceoğlu N, Yargucu F, Pirildar T, Oksel F (2010) Corneal hysteresis, corneal resistance factor, and intraocular pressure measurement in patients with scleroderma using the reichert ocular response analyzer. Cornea 29(6):628–631CrossRefPubMed Emre S, Kayikçioğlu O, Ateş H, Cinar E, Inceoğlu N, Yargucu F, Pirildar T, Oksel F (2010) Corneal hysteresis, corneal resistance factor, and intraocular pressure measurement in patients with scleroderma using the reichert ocular response analyzer. Cornea 29(6):628–631CrossRefPubMed
26.
Zurück zum Zitat Shih CY, Graff Zivin JS, Trokel SL et al (2004) Clinical significance of central corneal thickness in the management of glaucoma. Arch Ophthalmol 122:1270–1275CrossRefPubMed Shih CY, Graff Zivin JS, Trokel SL et al (2004) Clinical significance of central corneal thickness in the management of glaucoma. Arch Ophthalmol 122:1270–1275CrossRefPubMed
27.
Zurück zum Zitat Serup L, Serup J, Hagdrup H (1984) Increased central cornea thickness in systemic sclerosis. Acta Ophthalmol (Copenh) 62(1):69–74CrossRef Serup L, Serup J, Hagdrup H (1984) Increased central cornea thickness in systemic sclerosis. Acta Ophthalmol (Copenh) 62(1):69–74CrossRef
28.
Zurück zum Zitat Gomes BA, Santhiago M, Kara-Junior N et al (2011) Central corneal thickness in patients with systemic sclerosis: a controlled study. Cornea 30(10):1125–1128CrossRef Gomes BA, Santhiago M, Kara-Junior N et al (2011) Central corneal thickness in patients with systemic sclerosis: a controlled study. Cornea 30(10):1125–1128CrossRef
29.
Zurück zum Zitat Gomes BA, Santhiago MR, Kara-Junior N, de Azevedo MN, Moraes HV Jr (2015) Assessment of central corneal thickness in different subtypes of systemic sclerosis. Ocul Immunol Inflamm 11:1–6 Gomes BA, Santhiago MR, Kara-Junior N, de Azevedo MN, Moraes HV Jr (2015) Assessment of central corneal thickness in different subtypes of systemic sclerosis. Ocul Immunol Inflamm 11:1–6
30.
Zurück zum Zitat Atik SS, Koc F, Sari SA, Yurdakul NS, Ozmen M, Akar S (2015) Anterior segment parameters and eyelids in systemic sclerosis. Int Ophthalmol 36(4):577–583CrossRef Atik SS, Koc F, Sari SA, Yurdakul NS, Ozmen M, Akar S (2015) Anterior segment parameters and eyelids in systemic sclerosis. Int Ophthalmol 36(4):577–583CrossRef
31.
Zurück zum Zitat Garbe E, LeLorier J, Boivin JF et al (1997) Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids. Lancet 350:979–982CrossRefPubMed Garbe E, LeLorier J, Boivin JF et al (1997) Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids. Lancet 350:979–982CrossRefPubMed
32.
Zurück zum Zitat Iudici M, van der Goes MC, Valentini G, Bijlsma JW (2013) Glucocorticoids in systemic sclerosis: weighing the benefits and risks—a systematic review. Clin Exp Rheumatol 31(2 Suppl 76):157–165PubMed Iudici M, van der Goes MC, Valentini G, Bijlsma JW (2013) Glucocorticoids in systemic sclerosis: weighing the benefits and risks—a systematic review. Clin Exp Rheumatol 31(2 Suppl 76):157–165PubMed
33.
Zurück zum Zitat Gomes BF, Moraes HV Jr, Kara-Junior N, de Azevedo MN, de Lima FBF, Santhiago MR (2014) Intraocular pressure in chronic users of low-dose oral corticosteroids for connective tissue disease. Can J Ophthalmol 49(4):363–366CrossRefPubMed Gomes BF, Moraes HV Jr, Kara-Junior N, de Azevedo MN, de Lima FBF, Santhiago MR (2014) Intraocular pressure in chronic users of low-dose oral corticosteroids for connective tissue disease. Can J Ophthalmol 49(4):363–366CrossRefPubMed
Metadaten
Titel
Is there an association between glaucoma and capillaroscopy in patients with systemic sclerosis?
verfasst von
Beatriz Fiuza Gomes
Rebeca Souza
Thiago Valadão
Newton Kara-Junior
Haroldo Vieira Moraes
Marcony R. Santhiago
Publikationsdatum
06.05.2017
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 1/2018
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-017-0454-1

Weitere Artikel der Ausgabe 1/2018

International Ophthalmology 1/2018 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.